Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial

BACKGROUND: In a previous randomised controlled phase 2 trial, intravenous infusion of salbutamol for up to 7 days in patients with acute respiratory distress syndrome (ARDS) reduced extravascular lung water and plateau airway pressure. We assessed the effects of this intervention on mortality in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Fang Gao, Perkins, Gavin D, Gates, Simon, Young, Duncan, McAuley, Daniel F, Tunnicliffe, William, Khan, Zahid, Lamb, Sarah E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Publishing Group 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266479/
https://www.ncbi.nlm.nih.gov/pubmed/22166903
http://dx.doi.org/10.1016/S0140-6736(11)61623-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266479/
https://www.ncbi.nlm.nih.gov/pubmed/22166903
http://dx.doi.org/10.1016/S0140-6736(11)61623-1

Ejemplares similares